Maltese Laboratories incurred the following research and developments costs related to its pharmaceutical business: Internal projects (salaries, supplies, overhead for R&D facilities) -$ 620,000 Payment to acquire-R&D from a third party related to a specific project -75,000 Costs of an R&D project to be sold under contract to Libo Pharmacy, a third party- 82,000 In-process R&D associated with the acquisition of Curatics, an independent research company. -148,000 What amount should Maltese report as research and development expense in its income statement?